Janus Henderson Group
IGMS

Janus Henderson Group’s IGM Biosciences IGMS Stock Holding History

Janus Henderson Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-268,933
Closed -$20.6M – 1635
2021
Q1 		$20.6M Sell
268,933
-232,812
-46% -$21.2M 0.01% 763
2020
Q4 		$44.3M Sell
501,745
-343,190
-41% -$24.1M 0.02% 571
2020
Q3 		$62.4M Sell
844,935
-82,415
-9% -$4.88M 0.03% 441
2020
Q2 		$67.7M Sell
927,350
-551,455
-37% -$33.5M 0.04% 413
2020
Q1 		$79.8M Sell
1,478,805
-44,957
-3% -$1.97M 0.06% 333
2019
Q4 		$56M Buy
1,523,762
+997,235
+189% +$25.1M 0.03% 552
2019
Q3 		$9.35M Buy
+526,527
New +$10.6M 0.01% 966

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group's IGMS Position: Q2 2021 in Review

Janus Henderson Group sold out of IGM Biosciences (IGMS) in Q2 2021, closing a stake of 268,933 shares — an estimated $20.6M sold.

Janus Henderson Group first reported a position in IGMS in Q3 2019 and held it in 7 quarters. The position peaked at $79.8M in Q1 2020. 104 funds tracked by Wall St. Rank hold IGMS as of Q2 2021.

  • Janus Henderson Group reported no remaining IGM Biosciences position as of Q2 2021 after selling out during the quarter.
  • Janus Henderson Group sold 268,933 IGM Biosciences shares in Q2 2021, an estimated $20.6M.
  • Janus Henderson Group first reported a position in IGM Biosciences in Q3 2019 and held it in 7 quarters.
  • Janus Henderson Group's IGM Biosciences position peaked at $79.8M in Q1 2020.
  • 104 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2021.

Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.